AFFLUENT MEDICAL overview

Affluent Medical Affluent Medical announces coverage initiation of its stock by Gilbert Dupont – Société Générale Group. 04-Apr-2024 / 17:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. PRESS RELEASE Affluent Medical announces coverage initiation of its stock by Gilbert Dupont – Société Générale Group Aix-en-Provence, 4 April 2024 - 5:45 pm - Affluent Medical (ISIN: FR0013333077...

Affluent Medical Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap. 28-March-2024 / 17:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. PRESS RELEASE Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap Aix-en-Provence, 28 March 2024 - 5:45 pm - Affluent Medical (ISIN: FR0013333077 – Ticker: AFME), a French clinical-phase MedTech company...

Affluent Medical Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence. 12-March-2024 / 06:30 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. PRESS RELEASE Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence...

Affluent Medical Affluent Medical : Excellent valve performance at 1 year follow up and rising recognition of Epygon biomimetic mitral valve. 29-Feb-2024 / 17:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. PRESS RELEASE Excellent valve performance at 1 year follow up and rising recognition of Epygon biomimetic mitral valve Case study of the first successful human implantation published in an...

Affluent Medical Affluent Medical closes €3.5 million bridge via capital increase from key shareholders. 29-Jan-2024 / 18:15 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. PRESS RELEASE Affluent Medical closes €3.5 million bridge via capital increase from key shareholders Key shareholders provide bridge to continue exploring options to secure long term financing. The Company will continue to...

Affluent Medical Affluent Medical : Half-year liquidity contract statement for Affluent Medical. 29-Jan-2024 / 17:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. PRESS RELEASE Aix-en-Provence, January 29, 2024 Half-year liquidity contract statement for Affluent Medical Public limited company with a capital of € 30 896 652 Registered office: 320, avenue Archimède Les Pléiades III -...

Affluent Medical Affluent Medical : Pre-submission dossier for the 510(k) of medical device KaliosTM filed with FDA for review. 15-Jan-2024 / 17:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. PRESS RELEASE Pre-submission dossier for the 510(k) of medical device Kalios TM filed with FDA for review Assessments of the FDA review to be discussed in a meeting towards the end of the first quarter....

Affluent Medical Affluent Medical : Start of the European pilot study with the Artus medical device for the treatment of urinary incontinence. 06-Dec-2023 / 17:45 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. PRESS RELEASE Start of the European pilot study with the Artus medical device for the treatment of urinary incontinence Clinical investigation centres begin patient screening and...